ArticleFrontiers in public health2024
Evaluation of wastewater surveillance for SARS-CoV-2 in a prison population: a mixed-methods approach.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Infection Control in Carceral Facilities.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Review
- Near-source wastewater surveillance as a non-invasive tool for disease detection in prisons.Scientific reports · 2026Article
- A framework for evaluating implementation, impact, and cost-effectiveness of wastewater and environmental surveillance.Frontiers in public health · 2026Review
- Budget impact of wastewater surveillance for COVID-19 in a large urban jail: an activity-based cost analysis.Frontiers in public health · 2026Article
- Communicating wastewater-based surveillance data to drive action.Journal of water and health · 2025Review
- One-Year Monitoring of the Evolution of SARS-CoV-2 Omicron Subvariants Through Wastewater Analysis (Central Italy, August 2023-July 2024).Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prisons are high-risk settings for the transmission of communicable disease. Robust surveillance systems are required to identify and control outbreaks. Wastewater surveillance for SARS-CoV-2 was introduced in four prisons in Wales in March 2022. We investigated its contribution to the COVID-19 surveillance programme. Methods: We evaluated prison wastewater surveillance against eight system attributes using a mixed-methods approach. Semi-structured interviews were completed with key stakeholders to assess usefulness, flexibility and acceptability. Quantitative analyses were completed to assess data quality, sensitivity, positive-predictive value, representativeness and timeliness. To assess sensitivity of the system to detect changes in incidence we carried out a time-series analysis comparing levels of virus in wastewater with trends in confirmed COVID-19 cases from clinical surveillance. Results: Interviews with stakeholders indicated that wastewater surveillance is a useful adjunct to existing case-based surveillance. However, it had limited influence on action taken within the prison, often lagging behind existing surveillance and not specific enough to target interventions. The novelty of wastewater surveillance meant stakeholders lacked confidence in interpreting the data. Despite these limitations, wastewater surveillance detected changes in SARS-CoV-2 activity in Welsh prison populations which corroborated trends in case surveillance. Conclusion: Prison wastewater surveillance, implemented in Wales for a period during the COVID-19 pandemic, was useful and should be considered as part of a wider surveillance programme in response to future SARS-CoV-2 waves, or in response to future pandemics. It is particularly beneficial in the absence of comprehensive clinical testing. We identified several limitations to address should this surveillance be re-started.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.